52
Views
1
CrossRef citations to date
0
Altmetric
Original Research Article

Transdermal Buprenorphine in Clinical Practice: A Multicenter, Postmarketing Study in the Czech Republic, with a Focus on Neuropathic Pain Components

Pages 169-175 | Published online: 08 Mar 2012

References

  • Pergolizzi J , AloisiAM, DahanA et al. Current knowledge of buprenorphine and its unique pharmacological profile. Pain Pract. 10 , 428–450 (2010).
  • Vondráčková D . Transdermal buprenorphine for the treatment of moderate to severe chronic pain: results from a multicenter, non-interventional post-marketing study in the Czech Republic. Pain Manage.2(2) , 163–168 (2012).
  • Pergolizzi J , BögerRH, BuddK et al. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pain Pract. 8 , 287–313(2008).
  • Böhme K , LikarR. Efficacy and tolerability of a new opioid analgesic formulation, buprenorphine transdermal therapeutic system (TDS), in the treatment of patients with chronic pain. A randomised, double-blind, placebo-controlled study. Pain Clinic15 , 193–202 (2003).
  • Sittl R , GriessingerN, LikarR. Analgesic efficacy and tolerability of transdermal buprenorphine in patients with inadequately controlled chronic pain related to cancer and other disorders: a multicenter, randomized, double-blind, placebo-controlled trial. Clin. Ther.25 , 150–168 (2003).
  • Sorge J , SittlR. Transdermal buprenorphine in the treatment of chronic pain: results of a Phase III, multicenter, randomized, double-blind, placebo-controlled study. Clin. Ther.26 , 1808–1820 (2004).
  • Griessinger N , SittlR, LikarR. Transdermal buprenorphine in clinical practice – a post-marketing surveillance study in 13179 patients. Curr. Med. Res. Opin.21(8) , 1147–1156 (2005).
  • Pota V , BarbarisiM, SansoneP et al. Combination therapy with transdermal buprenorphine and pregabalin for chronic low back pain. Pain Manage. 2(1) , 23–31 (2012).

▪ Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.